Company Filing History:
Years Active: 2020-2023
Title: The Innovative Contributions of Paul Buxton
Introduction
Paul Buxton is a notable inventor based in Lucerne, Switzerland. He has made significant contributions to the field of biomedical engineering, particularly in the development of implant formulations. With a total of 3 patents to his name, Buxton's work focuses on enhancing the efficacy and usability of injectable implants.
Latest Patents
Buxton's latest patents include a dried implant composition and an injectable aqueous implant formulation. The dried implant composition is designed for preparing an injectable formulation that can be extruded through a tapering system and a gauge 18 cannula. This innovative composition includes a mixture of nanocrystalline hydroxyapatite particles derived from natural bone, sized between 50 to 200 µm, and fragments of naturally crosslinked fibrous collagen material that can pass through a 0.5 mm sieve. Additionally, the injectable aqueous implant formulation contains ascorbic acid and has been sterilized by gamma-ray or X-ray irradiation. This formulation can also be extruded through a tapering system with a force not exceeding 60 N, comprising 25-45 w/w % of the same mixture of hydroxyapatite and collagen.
Career Highlights
Paul Buxton is currently employed at Geistlich Pharma AG, a company renowned for its advancements in regenerative medicine. His work at Geistlich Pharma AG has allowed him to focus on innovative solutions that improve patient outcomes in the field of implants.
Collaborations
Throughout his career, Buxton has collaborated with talented professionals such as Daniel Suppiger and Nino Kurz. These collaborations have contributed to the development of groundbreaking technologies in the biomedical sector.
Conclusion
Paul Buxton's innovative work in the field of implant formulations showcases his dedication to advancing medical technology. His contributions are paving the way for more effective and user-friendly implant solutions.